Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.

Cai MY, Luo RZ, Chen JW, Pei XQ, Lu JB, Hou JH, Yun JP.

PLoS One. 2012;7(2):e32838. doi: 10.1371/journal.pone.0032838. Epub 2012 Feb 29.

2.

High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.

Li M, Luo RZ, Chen JW, Cao Y, Lu JB, He JH, Wu QL, Cai MY.

J Transl Med. 2011 Jan 5;9:5. doi: 10.1186/1479-5876-9-5.

3.

Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.

Fang Y, Wei J, Cao J, Zhao H, Liao B, Qiu S, Wang D, Luo J, Chen W.

PLoS One. 2013 May 2;8(5):e62558. doi: 10.1371/journal.pone.0062558. Print 2013.

4.

Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma.

Luo RZ, Cai PQ, Li M, Fu J, Zhang ZY, Chen JW, Cao Y, Yun JP, Xie D, Cai MY.

PLoS One. 2014 Jan 24;9(1):e85592. doi: 10.1371/journal.pone.0085592. eCollection 2014.

5.

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.

Liu F, Zhang Y, Peng Z, Gao H, Xu L, Chen M.

J Transl Med. 2012 Jul 2;10:135. doi: 10.1186/1479-5876-10-135.

6.

Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.

Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, Hood L, Wang H, Yang S, Gu J, Fan J, Qin W.

J Hepatol. 2009 May;50(5):948-57. doi: 10.1016/j.jhep.2008.11.020. Epub 2009 Jan 9.

PMID:
19303159
7.

Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.

Kahlert C, Lahes S, Radhakrishnan P, Dutta S, Mogler C, Herpel E, Brand K, Steinert G, Schneider M, Mollenhauer M, Reissfelder C, Klupp F, Fritzmann J, Wunder C, Benner A, Kloor M, Huth C, Contin P, Ulrich A, Koch M, Weitz J.

Clin Cancer Res. 2011 Dec 15;17(24):7654-63. doi: 10.1158/1078-0432.CCR-10-2816. Epub 2011 Oct 31.

8.

The "stone-like" pattern of LC3A expression and its clinicopathologic significance in hepatocellular carcinoma.

Xi SY, Lu JB, Chen JW, Cao Y, Luo RZ, Wu QL, Cai MY.

Biochem Biophys Res Commun. 2013 Feb 22;431(4):760-6. doi: 10.1016/j.bbrc.2012.12.151. Epub 2013 Jan 16.

PMID:
23333394
9.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
10.

High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection.

Jia JB, Wang WQ, Sun HC, Zhu XD, Liu L, Zhuang PY, Zhang JB, Zhang W, Xu HX, Kong LQ, Lu L, Wu WZ, Wang L, Tang ZY.

Oncologist. 2010;15(7):732-43. doi: 10.1634/theoncologist.2009-0170. Epub 2010 Jun 15.

11.

ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.

Bhardwaj M, Sen S, Sharma A, Kashyap S, Chosdol K, Pushker N, Bajaj MS, Bakhshi S.

Hum Pathol. 2015 Oct;46(10):1437-42. doi: 10.1016/j.humpath.2015.05.026. Epub 2015 Jun 10.

PMID:
26220160
12.

Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.

Liu B, Zhang J, Huang C, Liu H.

PLoS One. 2012;7(8):e43147. doi: 10.1371/journal.pone.0043147. Epub 2012 Aug 13.

13.
14.

[High expression of thrombin receptor PAR1 in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma in early stage].

Zhang XF, Dong QZ, Xue YH, Zhou HJ, Ye QH, Ren N, Jia HL, Qin LX.

Zhonghua Gan Zang Bing Za Zhi. 2011 Apr;19(4):266-70. doi: 10.3760/cma.j.issn.1007-3418.2011.04.009. Chinese.

PMID:
21586224
15.

Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.

Li T, Zhu Y, Qin CY, Yang Z, Fang A, Xu S, Ren W.

J Clin Pathol. 2012 Sep;65(9):808-14. doi: 10.1136/jclinpath-2012-200721. Epub 2012 Jun 25.

PMID:
22734007
16.

Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.

Xia L, Huang W, Tian D, Zhang L, Qi X, Chen Z, Shang X, Nie Y, Wu K.

Hepatology. 2014 Mar;59(3):958-73. doi: 10.1002/hep.26735. Epub 2014 Feb 6.

PMID:
24005989
17.

Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.

Kim SH, Ahn S, Park CK.

Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):51-9.

PMID:
22251470
18.

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, Wu WZ, Wang L, Tang ZY, Sun HC.

J Clin Oncol. 2008 Jun 1;26(16):2707-16. doi: 10.1200/JCO.2007.15.6521. Erratum in: J Clin Oncol. 2013 Aug 20;31(24):3049. J Clin Oncol. 2008 Jul 20;26(21):3659.

PMID:
18509183
19.

Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.

Nahm JH, Kim H, Lee H, Cho JY, Choi YR, Yoon YS, Han HS, Park YN.

Tumour Biol. 2016 Jan;37(1):393-403. doi: 10.1007/s13277-015-3810-7. Epub 2015 Jul 29.

PMID:
26219896
20.

Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.

Fang F, Luo LB, Tao YM, Wu F, Yang LY.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):409-16. doi: 10.1158/1055-9965.EPI-08-0575.

Supplemental Content

Support Center